help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hämäläinen, T.
Right arrow Articles by Huhtaniemi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hämäläinen, T.
Right arrow Articles by Huhtaniemi, I.
Endocrinology Vol. 143, No. 10 4096-4103
Copyright © 2002 by The Endocrine Society


ARTICLE

Transgenic Mice Harboring Murine Luteinizing Hormone Receptor Promoter/ß-Galactosidase Fusion Genes: Different Structural and Hormonal Requirements of Expression in the Testis, Ovary, and Adrenal Gland

Tuula Hämäläinen, Jukka Kero, Matti Poutanen and Ilpo Huhtaniemi

Department of Physiology, University of Turku, FIN-20520 Turku, Finland

Address all correspondence and requests for reprints to: Professor Ilpo T. Huhtaniemi, Department of Physiology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland. E-mail: ilpo.huhtaniemi{at}utu.fi.

In vivo regulation of the LH receptor (LHR) promoter was studied using transgenic (TG) mice harboring fusion genes containing three different lengths of the LHR promoter (7.4 kb, 2.1 kb, and 173 bp), fused with coding sequence of the Escherichia coli ß-galactosidase (ß-GAL) reporter gene. The length of the LHR promoter significantly affected the pattern of ß-GAL expression. In the testis the shortest promoter directed expression primarily of the full-length ß-GAL mRNA, but mainly truncated messages were transcribed from the longer LHR promoter/ß-GAL constructs. The case was reversed in the ovary and adrenal gland. Furthermore, we have recently detected strong LHR expression in the adrenal gland of female mice with chronically elevated serum LH. Therefore, the regulation of the adrenal LHR expression was addressed in the present study using the LHR/ß-GAL TG mice. Elevated LH levels were achieved in the LHR/ß-GAL mice either by gonadectomy or cross-breeding them with TG mice overexpressing a chimeric protein of bovine LH ß-subunit and the C-terminal fragment of human chorionic gonadotropin-ß. In both models, ß-GAL mRNA was found in the adrenal cortex when the 7.4-kb LHR promoter was applied but not in mice carrying the 173-bp LHR promoter. The 7.4-kb construct was activated also in the ovaries in the double TG LHR(ß-GAL)/bovine LH ß-subunit/C-terminal fragment of human chorionic gonadotropin-ßmice in some theca-interstitial cells surrounding the follicles. Hence, the LHR promoter elements essential for directing ß-GAL expression to the adrenal gland and ovary (7.4 kb) are different from those recently shown to be essential for the testicular expression (173 bp). In conclusion, elevated serum LH concentrations were found seminal for the LHR promoter activation in the ovaries and adrenals, and different lengths of the promoter are responsible for reporter gene expression in the testis, ovary, and adrenal gland.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. J. Marx and W. F. Simonds
Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes
Endocr. Rev., August 1, 2005; 26(5): 615 - 661.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. M. Apaja, J. T. Aatsinki, H. J. Rajaniemi, and U. E. Petaja-Repo
Expression of the Mature Luteinizing Hormone Receptor in Rodent Urogenital and Adrenal Tissues Is Developmentally Regulated at a Posttranslational Level
Endocrinology, August 1, 2005; 146(8): 3224 - 3232.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Bachelot, G. Meduri, N. Massin, M. Misrahi, F. Kuttenn, and P. Touraine
Ovarian Steroidogenesis and Serum Androgen Levels in Patients with Premature Ovarian Failure
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2391 - 2396.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Bielinska, H. Parviainen, S. B. Porter-Tinge, S. Kiiveri, E. Genova, N. Rahman, I. T. Huhtaniemi, L. J. Muglia, M. Heikinheimo, and D. B. Wilson
Mouse Strain Susceptibility to Gonadectomy-Induced Adrenocortical Tumor Formation Correlates with the Expression of GATA-4 and Luteinizing Hormone Receptor
Endocrinology, September 1, 2003; 144(9): 4123 - 4133.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society